Cardiovascular Disease Prevention

Prevention of Heart Failure With Non-pharmacological Interventions

by Prateek Chopra | May 21, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure (HF) prevention increasingly focuses on early modification of upstream cardiometabolic risk factors through lifestyle and dietary interventions. Emerging evidence suggests that non-pharmacological strategies targeting hypertension, obesity, diabetes, physical inactivity, and adverse dietary patterns may significantly reduce future HF risk, particularly heart failure with preserved ejection fraction […]

Prevention of Heart Failure With Non-pharmacological Interventions Read Post »

Leave a Comment / ESC-HF Day 2 / / / , , , ,

Managing the Complex Hypertensive Patients in a Multi-Morbid World

by Prateek Chopra | June 14, 2026 | Cardiology Conferences | ESH 2026 Research Objective: Examine the epidemiological burden of multimorbidity in hypertension, the interplay between HTN and common comorbidities, and evidence-based strategies for cardiovascular risk reduction in complex hypertensive patients. Study Context: Evidence and Data Sources: Patient Profile and Key Findings: Management requires individualized, goal-directed therapy focused on reducing cardiovascular

Managing the Complex Hypertensive Patients in a Multi-Morbid World Read Post »

Leave a Comment / ESH Day 3 / / / , , , ,

Immunization and Cardiovascular Protection: Evidence andFuture Directions

by Prateek Chopra | June 12, 2026 | Cardiology Conferences | ESH 2026 Clinical Rationale: Growing evidence supports a bidirectional relationship between infections and cardiovascular disease (CVD). Respiratory infections can trigger acute cardiovascular events and exacerbate pre-existing conditions, while patients with underlying CVD are at higher risk of severe infectious outcomes. Influenza infection, for example, increases the incidence of acute myocardial

Immunization and Cardiovascular Protection: Evidence andFuture Directions Read Post »

Leave a Comment / ESH Day 3 / / / , , , ,

Triple SPCs: Simplifying Treatment, Strengthening Control

by Prateek Chopra | June 8, 2026 | Cardiology Conferences | ESH 2026 Simplifying Hypertension Care: Despite hypertension being a leading contributor to cardiovascular morbidity and mortality, BP control remains suboptimal due to poor adherence, therapeutic inertia, and complex multi-drug regimens. Triple single-pill combinations (SPCs) simplify therapy, improve adherence, accelerate BP target attainment, and enhance long-term cardiovascular outcomes. Guideline-Based Recommendations: Real-World

Triple SPCs: Simplifying Treatment, Strengthening Control Read Post »

Leave a Comment / ESH Day 2 / / / , , , ,

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome?

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESH 2026 Study Objective: Evaluate whether lifestyle interventions can prevent progression of cardiac damage across different stages of CKM syndrome. Evidence Across CKM Stages: Stage 0 (Pre-risk / Children): Stage 2 (Metabolic Risk / Subclinical Disease): Stage 3 (Silent Cardiac Damage): Stage 4 (Established CVD / Secondary Prevention): Clinical Implications

Time for Change: Can Lifestyle Interventions Prevent theEvolution of Cardiac Damage in Patients with CKM Syndrome? Read Post »

Leave a Comment / ESH Day 1 / / / , , , ,
Scroll to Top